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As women approach midlife, hormonal changes and related health issues result in their becoming 
potential candidates for a range of health technologies. These are promoted as beneficial for 
maintaining, enhancing and managing their current and future health and quality of life.  A recent 
study focused on three linked health technologies: the use of hormone replacement therapy (HRT) 
for the prevention of osteoporosis and cardiovascular disease; screening for osteoporosis using 
bone densitometry; and screening for breast cancer using mammography screening and ‘breast 
awareness’.  These technologies, particularly HRT, are much discussed in the media.  The study 
examined areas in which there has been little previous research: women’s own assessments of the 
risks and benefits involved; the medical and informal knowledge women draw upon; and how social 
and cultural contexts and women’s own agency affect these health-relevant decisions. 
Key findings
Women and health 
technologies: 
The health concerns of women at midlife vary and must not be treated as the same.  The social, 
economic and cultural contexts of women’s lives and the range of their experiences all need to 
be considered.
The medicalisation of the menopause, the shift towards personal responsibility for health, and 
women’s own feelings of agency are all central to understanding women’s relationships to 
health technologies.
Women’s views and experiences of mammography, bone densitometry and hormone 
replacement therapy were often quite different; each technology should be treated as discrete 
and having diverse meanings.
This sample of midlife women said they knew less about bone densitometry and used it much 
less often than they did HRT and mammography.
Women drew on a variety of knowledge, lay and expert, as well as their own experiences, to 
make sense of the health technologies and health-relevant options facing them at midlife.
Women’s decisions about these technologies are rarely based simply on medical or scientific 
grounds, but involve complex assessments of the wider landscape of social and health risks 
and benefits.
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The Study 
This report focuses on one part of a larger qualitative 
study, conducted in two socio-economically contrasting 
areas in England. It examined the approaches to, and 
understandings of, health technologies by midlife women 
and a range of health professionals in order to understand 
the social processes and contexts involved in their use. 
Midlife was defined as the years between the ages of 45 
and 64. A total of 98 women was interviewed, sampled for 
diversity of background on the following dimensions: use 
of the health technologies, ethnicity, sexual orientation, 
disability and socio-economic characteristics. Interviews 
were also conducted with 58 health professionals, working 
in a variety of health care settings, and 109 relevant 
consultations from primary and secondary health care 
were recorded.  Here we report some key findings from the 
analysis of the midlife women’s interviews.
Background: women, medicalisation and 
health technologies.
The study built on a growing body of work, particularly 
by feminist researchers, on women’s health at midlife. 
Such research developed partly as a counter to dominant 
biomedical ideas, which tended to portray midlife women’s 
bodies in universal and undifferentiated terms.  It is argued 
that, particularly at the time of menopause, women’s 
bodies begin to be depicted as ageing, leaking hormones, 
and ‘failing’.  As such, they become the primary target of 
‘medicalisation’, which renders women as passive recipients 
of treatment.  It is claimed that the increasing objectification 
of the menopause as a ‘disease’ treats women’s bodies 
as problematic and imbued with negative metaphors of 
decay and degeneration.  Other sociological critiques of 
the biomedical model show that women’s experiences of 
the menopause are quite different in other cultural contexts 
and that their health care and health care practices need to 
be seen in the context of issues of gender and other social 
divisions, such as class, ethnicity and age.  
At the same time, other analysts argue that there has 
been a partial demise of the biomedical model and that, 
increasingly, we are being subjected to a form of social 
control founded on self-regulation, self-monitoring and the 
avoidance of ‘risk’ through developing healthy lifestyles 
and keeping well.  This is seen as placing particular 
additional responsibilities on women who, in line with the 
rise of an emphasis on individual responsibility and the role 
of ‘experts’, are encouraged to monitor their own health 
lifestyles (and those of their families) and to participate in a 
range of screening programmes.
More recently, however, there has been a renewed focus 
on women’s own decision making in these processes.  This 
is based on an acknowledgment that health maintaining 
practices are not ‘stand alone’ but are made sense of, 
and taken up by, women in terms of their own lives and 
experiences.  This may also involve challenges to experts’ 
judgements about risk.  Moreover, some researchers have 
argued that, far from being victims, women themselves 
seek out health technologies to improve their lives, treating 
these as ‘lifestyle choices’ to counter the effects of ageing 
and as opportunities to ‘reinvent’ themselves.1  
Findings
Views and experiences about the health 
technologies
From the interviews it was evident that women’s decisions 
about these health technologies were rarely based 
upon purely medical or scientific grounds.  Rather, such 
decisions reflected women’s present concerns, embodied* 
experiences, experiences of health and health care, and a 
complicated mixture of expert, lay and experience-based 
knowledge.  Perhaps unsurprisingly, there was considerable 
diversity within our sample in their attitudes towards these 
technologies.  However, just as it is important not to treat 
midlife women and their experiences as the same, so 
the research showed that each of the three technologies 
elicited a range of views and experiences.
Mammography: health screening as social 
obligation
Most of the sample expressed positive views about breast 
screening; it seemed that women trust this technology and 
the ‘experts’ behind it.  From all of our data sources it was 
also apparent that mammography was rarely discussed 
with health professionals and its safety seldom questioned 
by these midlife women.  Of the women interviewed, 85% of 
those eligible had taken up mammography screening; those 
who declined came from diverse backgrounds.  Interviewees 
spoke about mammography in ways suggesting that it was 
seen as a routinised, often unquestioned, social obligation. 
Because this technology is available as part of a national, 
publicly funded screening programme for women over 50 
in the UK, it seemed that, as ‘responsible citizens’, most 
interviewees felt obliged to participate in order to reduce 
the incidence of breast cancer.  Even those women in our 
sample who felt ambivalent about the experience itself, 
often speaking of the pain and discomfort involved, still 
expressed the feeling of obligation.  For example, one 
woman whose first mammography had been ‘absolutely 
horrendous’, still spoke of mammography as ‘the norm’ 
explaining that: 
‘I was really quite frightened to go the second time, but 
even though I was, I know it was important for me to go’ 
(woman no. 60)
Bone Densitometry: the importance of being 
within the ‘normal’ range.
In comparison, lay knowledge about and use of bone 
densitometry was much lower than the other two 
technologies studied. Consequently, fewer interviewees 
expressed specific opinions about this technology; those 
*‘Embodiment’ is a social science term which emphasises the interconnectedness of the emotional and physical self and how this is experienced in 
everyday social life.  
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who did were either neutral or positive in their views.  From 
the interviews with the subsample who had experience or 
knowledge of bone densitometry (and from relevant rec-
orded consultations), it seemed that women focused on how 
the results of the test should be interpreted and how ‘bone 
management’ could keep them within the perceived range 
of ‘normal’.  Technology was central to decision making in 
the bone/HRT clinics.  Results are in the form of a numerical 
measurement, which is then interpreted as above or below 
‘normal’.  The data from health professionals indicated that 
they knew, and often indicated to patients, that the bone 
densitometry result is only one indicator of potential risk of 
osteoporosis.  Nevertheless, it appeared that most of those 
interviewed perceived these results as enabling ‘objective’ 
and precise calculation of future health risk and, as the next 
quotation suggests, many of these interviewees seemed to 
be seeking certainties of diagnosis:
‘and then she (Doctor) suggested I went and had, umm, the 
bone density checked (following a fracture of the foot), 
which I did and it wasn’t very good at that point, it was 
just teetering off the bottom end of normal and from that 
point of view I was aware that the HRT should help and 
prevent or reduce the risk of sort of osteoporosis.  It was 
really only from that point of view that I decided to take 
it’ (woman no. 61)
Hormone Replacement Therapy: an embodied 
experience
Over half the midlife women interviewed had used HRT. 
These women were from a range of income groups, 
had differing levels of educational attainment, and were 
representative of the range of community and health care 
groups in the sampling frame.  Although usage and attitudes 
towards HRT varied within these diverse groupings, lesbian 
women and those from ethnic minorities were less likely to 
have taken it.  Concerns about its production and safety 
were the main reasons given for not using HRT by the 
sample as a whole, as the following quotation illustrates:
‘Well HRT has been offered when I’ve been, there’s a nurse 
there, but I don’t really want to go on it.  Em, not through 
choice, I wouldn’t go on but if I had to and I felt it was 
advantageous to me then... I think there are certain risks 
to it and certainly my elder son’s mother-in-law developed 
breast cancer which she was then told at the hospital was 
directly attributable to the HRT she had been on’ 
(woman no. 18)
Women’s decision making about taking HRT was multi-
faceted and complex.  Interestingly, although most health 
professionals interviewed said that discussing risks of HRT 
was important, only a minority of the midlife women in our 
sample recalled such discussions taking place.  A minority 
of women reported that one overwhelming factor had 
dominated their decision making.  These included bodily 
experiences, such as multiple sclerosis or depression; 
social factors, such as a new job or concern about 
intimate relations; a medical intervention, for example a 
hysterectomy.  Most interviewees, however, described 
a more incremental process, gradually changing their 
decision threshold, with 29 women describing precipitating 
factors, often connected with embodied experiences such 
as insomnia or hot flushes, which ‘tipped the balance’.
Social and cultural influences on women’s 
decision making
Whose knowledge is it anyway?
From the interviews it was evident that women’s embodied 
health experiences, concepts of social and health risks, 
and their perception of access to sympathetic health care 
all influenced their decision making about these health 
technologies.  The process of making sense of their options 
involved drawing on a variety of knowledge from popular 
media sources, local lay sources, direct experiences of 
friends and family as well as from health professionals. 
Each woman assessed the relevance of these varied kinds 
of knowledge for her own particular circumstances in the 
light of her personal embodied experience and outlook, as 
is illustrated by the following quotation from one woman, 
who had not yet had a mammogram:
‘I have no personal knowledge of it (breast screening), ’cos 
I’ve never actually been but I have quite strong feelings 
on the treatment I would ask for if I did have it (cancer).  
So I suppose really I’m putting off going in case there is 
anything wrong... But I think I’m being a little bit like, em, 
sticking my head in the sand.  It’s quite a difficult thing to 
discuss with people because very few people feel like that, 
and really it just goes back to a programme I saw a long 
time ago on television... As I say my friends, none of my 
friends feel the same as I do, so it’s easier not to discuss 
it’ (woman no. 50)
Weighing up the risks and benefits
The assessment of health and social risks at midlife and the 
part played by health technologies was another dominant 
theme. Seeking reassurance or greater understanding 
about the risks and benefits of health technologies could be 
seen as part of the development of ‘information landscapes’. 
These landscapes signify the spaces and places where 
people actively or passively acquire information about 
health and then take ‘patient pathways’ through them in 
an attempt to understand and manage health issues.  In 
the present study, however, when asked if they felt they 
had sufficient information for decision making about the 
technologies, only a minority of midlife women said they 
did.  This was particularly noteworthy with regard to HRT, 
which was the technology most interviewees chose to talk 
about when discussing their health needs.  The following 
quotation, where the interviewee cannot remember if risks 
and benefits of HRT were discussed, was typical:
Int: You said before that health professionals haven’t 
given you enough information sometimes. But, um, do you 
think they have raised the question of safety and risks in 
relation to health care? Like HRT, did they ever mention, 
you know, the risks that might be involved?
R: ‘Mmm, they might have done... I don’t think... perhaps I 
didn’t want to hear about the risks’ 
Int:  (laughs) OK.




1Griffiths, F. (1999) Women’s control and choice regarding HRT. Social Science and Medicine 49, 469-481.
This study was part of a larger project - Griffiths, F., Green, E., Bendelow, G., Backett-Milburn, K. (2003) Innovative Health Technologies at 
Women’s Midlife: Theory and Diversity among Women and ‘Experts’. End of Award Report (L218252038) Economic and Social Research 
Council, Swindon, UK. ESRC website www.esrc.ac.uk.
Di Thompson and Maria Tsouroufli were Research Associates on the project. This Findings was written by Kathryn Backett-Milburn and 
edited by Sarah Morton. Any enquiries about this work should be made to k.milburn@ed.ac.uk. 
●
RUHBC research findings 7
When asked about the nature of the decision making 
process with health professionals about taking HRT, and 
whether this was shared, one third said that it was a shared 
decision, half that it was the health professional’s decision 
and one sixth that it was their own decision.  In contrast, the 
majority of health professionals said they aim for shared 
decision making with women in relation to HRT.  Some 
women pointed to constraints on health professionals, 
including time and the types of health care they are able 
to discuss, which, according to our interviewees, rarely 
includes alternative therapies. 
Given these findings, it is important to consider the wider 
landscape of risk, most notably social risks and benefits, 
which our interviews showed to be important in women’s 
decision making.  Perceived social risks related to, for 
example: appearance, including weight gain; becoming 
dependent on others; personal relationships; and the 
workplace. Interviewees commonly expressed concern 
about gaining weight, and its subsequent effects on self 
esteem and self identity, as one of the perceived negative 
side effects of taking HRT.  However, for many, this was 
weighed against the social risks attached to experiencing 
severe menopausal symptoms, and feeling out of control 
of their bodies in different situations and places, such as 
the home and workplace.  The following woman recounted, 
particularly vividly, her embodied experiences leading to the 
decision to take HRT.  At home she was affected by being 
too hot at nights, leading to sleeplessness and fatigue.  At 
work, she found hot flushes particularly hard to cope with in 
meetings, describing the experience as follows:
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There is a need for greater appreciation of the 
knowledge on which women base their health relevant 
decisions, particularly the ways in which everyday 
knowledge, media messages and experience mix with 
expert knowledge.
The design of the health care system for women at 
midlife needs to take account of the social and cultural 
contexts and how these influence women’s decision 
making processes.
The style of communication in technology-related 
health care consultations and health education could 
be improved by taking account of these findings.
‘I think usually I just kind of tried to keep quiet and let 
the meeting go on without me, em, perhaps be not quite as 
involved in the meeting as I would have been normally, you 
know.  Kind of not wanting to draw attention to myself.  Um, 
and feeling quite uncomfortable and just wanting to run 
basically.  It’s actually quite hard to maintain the thread, 
you know, and your concentration.  The more I think about 
my group of friends or work colleagues, I can’t think of 
anybody who is not on some form of HRT in the kind of 
medium to long term’ (woman no. 52) 
Implications
At present there is concern about the nature of the 
interaction between technology and society.  The findings 
from this study lead us towards increased understanding of 
the social and cultural contexts of midlife women’s decision 
making about health technologies, in particular:
●
●
Centre for Research on Families and Relationships
The University of Edinburgh, 23 Buccleuch Place, 
Edinburgh EH8 9LN. 
Tel: 0131-651 1832    Fax: 0131-651 1833    
Email: crfr@ed.ac.uk
For a full list of Research Briefings visit our website 
www.crfr.ac.uk
RUHBC
Research Unit in Health, Behaviour and Change
School of Clinical Sciences and Community Health,
The University of Edinburgh, Medical School, 
Teviot Place, Edinburgh EH8 9AG. 
Tel: 0131-650 6192/3    Fax: 0131-650 6902    
For a full list of Research Findings visit our website 
www.chs.med.ac.uk/ruhbc
CRFR
Contact details
